BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6584630)

  • 41. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of uterine activity. Using oxytocin after intracervical PGE2.
    Coleman FH; Rayburn WF; Burks LS; Farmer KC; Larson JD; Turnbull GL
    J Reprod Med; 1997 Jan; 42(1):44-8. PubMed ID: 9018645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
    Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y
    Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uterine hyperstimulation resulting from intravaginal prostaglandin E2. A case report.
    Chamberlin RO; Cohen GR; Knuppel RA
    J Reprod Med; 1987 Mar; 32(3):233-5. PubMed ID: 3471969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Labor induction with prostaglandin E2 in post-term pregnancy-- results of a multicenter study].
    Wischnik A; Rath W
    Zentralbl Gynakol; 1994; 116(9):537-43. PubMed ID: 7975966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
    Owen J; Hauth JC
    J Matern Fetal Med; 1999; 8(2):48-50. PubMed ID: 10090490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-administered outpatient intravaginal prostaglandin E2 suppositories in post-date pregnancies: a double-blind, randomized, placebo-controlled study.
    Sawai SK; O'Brien WF; Mastrogiannis DS; Krammer J; Mastry MG; Porter GW
    Obstet Gynecol; 1994 Nov; 84(5):807-10. PubMed ID: 7936516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of dinoprostone gel and gemeprost suppositories for induction of abortion in the second and third trimester].
    Mink D; Heiss C; Rothbrust S; Schmidt W
    Zentralbl Gynakol; 1995; 117(5):263-8. PubMed ID: 7793169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intravenous administration of prostaglandin F2alpha or prostaglandin E2 in labor pain induction in fetal death].
    Klausch B; Kruse HJ; Junge WD; Göretzlehner G
    Zentralbl Gynakol; 1974 Nov; 96(48):1505-13. PubMed ID: 4458350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of spontaneous labor with induced vaginal tablets prostaglandin E2 in grand multiparae.
    Sobande AA; Al-Bar HM; Archibong EI
    Saudi Med J; 2001 Aug; 22(8):698-701. PubMed ID: 11573116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical experiences with prostaglandin E 2 and F 2 alpha in the termination of pregnancy and labor induction in intrauterine fetal death].
    Kunz J; Schreiner WE
    Schweiz Med Wochenschr; 1977 Jun; 107(22):757-63. PubMed ID: 877524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracervical application of prostaglandin gel for induction of term labor.
    Ulmsten U; Wingerup L; Belfrage P; Ekman G; Wiqvist N
    Obstet Gynecol; 1982 Mar; 59(3):336-9. PubMed ID: 7043341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of labor. A double-blind randomized controlled study of prostaglandin E2 vaginal suppositories compared with intranasal oxytocin and with sequential treatment.
    Andreasson B; Bock JE; Larsen J
    Acta Obstet Gynecol Scand; 1985; 64(2):157-61. PubMed ID: 3885670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A clinical trial of induction of labor versus expectant management in postterm pregnancy. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
    Am J Obstet Gynecol; 1994 Mar; 170(3):716-23. PubMed ID: 7710467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of failed prostaglandin abortions.
    Lauersen NH; Wilson KH; Zervoudakis IA; Saary Z
    Obstet Gynecol; 1976 Apr; 47(4):473-8. PubMed ID: 943738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandins: an alternative concept for induction of labor.
    Shepherd JH; Knuppel RA
    South Med J; 1980 Nov; 73(11):1476-7. PubMed ID: 7444512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of prostaglandin E2 in labor induction and stimulation].
    Andrev Zh; Borisov I; Mateeva E
    Akush Ginekol (Sofiia); 1983; 22(4):285-90. PubMed ID: 6584044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.